Nobivac Feline HCPCh+FeLV
Nobivac Feline 1-HCPCh+FeLV vaccine is a combination vaccine that unites the benefits of Nobivac Feline 1-HCPCh and Nobivac 2-FeLV in one vaccination.
Nobivac Feline 1-HCPCh vaccine is a modified live virus and chlamydia vaccine for the vaccination of healthy cats as an aid in the prevention of disease caused by feline rhinotracheitis, calici, and panleukopenia viruses and Chlamydia psittaci.
Nobivac 2-FeLV vaccine is recommended for the vaccination of healthy cats as an aid in the prevention of lymphoid tumors caused by, and diseases associated with, feline leukemia virus (FeLV) infection. Vaccination with this product prevents persistent viremia in cats exposed to virulent feline leukemia virus. The feline leukemia virus, subgroups A and B, are cultured in tissue culture cells. The virus has been chemically inactivated and combined with a proprietary adjuvant designed to enhance the immune response.
Revaccinate every 2 years with Nobivac Feline 2-FeLV after initial series. Revaccination in the intervening years with Nobivac Feline 1-HCPCh is recommended.